Grandchamp Sophie, Blanc Anne-Laure, Roussel Marine, Tagan Damien, Sautebin Annelore, Dobrinas-Bonazzi Maria, Widmer Nicolas
Pharmacy of the Eastern Vaud Hospitals, Route du Vieux Séquoia 20, 1847, Rennaz, Switzerland.
Riviera-Chablais Hospital, Vaud-Valais, Rennaz, Switzerland.
Drugs Real World Outcomes. 2022 Jun;9(2):253-261. doi: 10.1007/s40801-021-00288-x. Epub 2021 Dec 31.
Transition between hospital and ambulatory care is a delicate step involving several healthcare professionals and presenting a considerable risk of drug-related problems.
To investigate pharmaceutical interventions made on hospital discharge prescriptions by community pharmacists.
This observational, prospective study took place in 14 community pharmacies around a Swiss acute care hospital. We recruited patients with discharge prescriptions (minimum three drugs) from the internal medicine ward of the hospital. The main outcome measures were: number and type of pharmaceutical interventions made by community pharmacists, time spent on discharge prescriptions, number of medication changes during the transition of care.
The study included 64 patients discharged from the hospital. Community pharmacists made a total of 439 interventions; a mean of 6.9 ± 3.5 (range 1-16) interventions per patient. All of the discharge prescriptions required pharmaceutical intervention, and 61 (95%) necessitated a telephone call to the patients' hospital physician for clarifications. The most frequent interventions were: confirming voluntary omission of a drug (31.7%), treatment substitution (20.5%), dose adjustment (16.9%), and substitution for reimbursement issues (8.8%). Roughly half (52%) of all discharge prescriptions required 10-20 min for pharmaceutical validation. The mean number of medication changes per patient was 16.4: 9.6 changes between hospital admission and discharge, 2.6 between hospital discharge and community pharmacy, and 4.2 between community pharmacy and a general practitioner's appointment.
Hospital discharge prescriptions are complex and present a significant risk of medication errors. Community pharmacists play a key role in preventing and identifying drug-related problems.
医院护理与门诊护理之间的过渡是一个微妙的阶段,涉及多名医护人员,且存在药物相关问题的重大风险。
调查社区药剂师对出院处方进行的药学干预。
这项观察性前瞻性研究在瑞士一家急症医院周边的14家社区药房开展。我们从该医院内科病房招募了有出院处方(至少三种药物)的患者。主要观察指标包括:社区药剂师进行的药学干预的数量和类型、处理出院处方所花费的时间、护理过渡期间药物变更的数量。
该研究纳入了64名出院患者。社区药剂师共进行了439次干预;每位患者平均干预6.9 ± 3.5次(范围为1 - 16次)。所有出院处方均需要药学干预,其中61份(95%)需要致电患者的医院医生进行澄清。最常见的干预措施为:确认自愿停用某种药物(31.7%)、治疗替代(20.5%)、剂量调整(16.9%)以及因报销问题进行替代(8.8%)。大约一半(52%)的出院处方需要10 - 20分钟进行药学验证。每位患者药物变更的平均数量为16.4次:入院与出院之间变更9.6次,出院与社区药房之间变更2.6次,社区药房与全科医生预约之间变更4.2次。
出院处方复杂,存在用药错误的重大风险。社区药剂师在预防和识别药物相关问题方面发挥着关键作用。